Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 708

1.

Cardiovascular outcomes in patients with primary aldosteronism after treatment.

Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA.

Arch Intern Med. 2008 Jan 14;168(1):80-5. doi: 10.1001/archinternmed.2007.33.

PMID:
18195199
2.

Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.

Novello M, Catena C, Nadalini E, Colussi GL, Baroselli S, Chiuch A, Lapenna R, Bazzocchi M, Sechi LA.

J Hypertens. 2007 Jul;25(7):1443-50.

PMID:
17563567
3.

[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].

Szücs N, Gláz E, Varga I, Tóth M, Kiss R, Patócs A, Jakab C, Perner F, Járay J, Horányi J, Dabasi G, Molnár F, Major L, Füto L, Rácz K, Tulassay Z.

Orv Hetil. 2006 Jan 15;147(2):51-9. Hungarian.

PMID:
16509213
4.

High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.

Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM.

J Hypertens. 2003 Nov;21(11):2149-57.

PMID:
14597859
6.

Factors influencing outcome of surgery for primary aldosteronism.

Celen O, O'Brien MJ, Melby JC, Beazley RM.

Arch Surg. 1996 Jun;131(6):646-50.

PMID:
8645073
7.

Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.

Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, Sechi LA.

Hypertension. 2007 Nov;50(5):911-8.

8.

Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.

Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M.

J Hypertens. 2007 Jan;25(1):177-86.

PMID:
17143190
9.

Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?

Proye CA, Mulliez EA, Carnaille BM, Lecomte-Houcke M, Decoulx M, Wémeau JL, Lefebvre J, Racadot A, Ernst O, Huglo D, Carré A.

Surgery. 1998 Dec;124(6):1128-33.

PMID:
9854594
10.

Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.

Mourad JJ, Girerd X, Milliez P, Lopez-Sublet M, Lejeune S, Safar ME.

Am J Hypertens. 2008 Jul;21(7):742-7. doi: 10.1038/ajh.2008.175.

PMID:
18443567
11.

Primary aldosteronism: factors associated with normalization of blood pressure after surgery.

Sawka AM, Young WF, Thompson GB, Grant CS, Farley DR, Leibson C, van Heerden JA.

Ann Intern Med. 2001 Aug 21;135(4):258-61.

PMID:
11511140
12.

Prediction of successful outcome in patients with primary aldosteronism.

Moo TA, Zarnegar R, Duh QY.

Curr Treat Options Oncol. 2007 Aug;8(4):314-21. Review.

PMID:
18058076
13.

Diagnosis and treatment of primary hyperaldosteronism.

Blumenfeld JD, Sealey JE, Schlussel Y, Vaughan ED Jr, Sos TA, Atlas SA, Müller FB, Acevedo R, Ulick S, Laragh JH.

Ann Intern Med. 1994 Dec 1;121(11):877-85.

PMID:
7978702
14.

Relationships of plasma renin levels with renal function in patients with primary aldosteronism.

Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA.

Clin J Am Soc Nephrol. 2007 Jul;2(4):722-31.

15.

Management of primary aldosteronism: its complications and their outcomes after treatment.

Giacchetti G, Turchi F, Boscaro M, Ronconi V.

Curr Vasc Pharmacol. 2009 Apr;7(2):244-49. Review.

PMID:
19356005
16.

Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.

Catena C, Colussi GL, Marzano L, Sechi LA.

Horm Metab Res. 2012 Mar;44(3):188-93. doi: 10.1055/s-0032-1301902.

PMID:
22351477
17.

Primary aldosteronism: renaissance of a syndrome.

Young WF.

Clin Endocrinol (Oxf). 2007 May;66(5):607-18. Review.

PMID:
17492946
18.

Long-term renal outcomes in patients with primary aldosteronism.

Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C.

JAMA. 2006 Jun 14;295(22):2638-45. Erratum in: JAMA. 2006 Oct 18;296(15):1842.

PMID:
16772627
19.

Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.

Ichikawa S, Tajima Y, Sakamaki T, Matsuo H, Kogure M, Hirano Y, Yagi S, Murata K.

Jpn Circ J. 1984 Nov;48(11):1184-96.

PMID:
6502914
20.

Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism.

Catena C, Colussi G, Di Fabio A, Valeri M, Marzano L, Uzzau A, Sechi LA.

Horm Metab Res. 2010 Jun;42(6):440-5. doi: 10.1055/s-0029-1246185. Review.

PMID:
20119883
Items per page

Supplemental Content

Support Center